Humana Inc. (NYSE:HUM) Shares Purchased by Brooklyn Investment Group

Brooklyn Investment Group boosted its holdings in shares of Humana Inc. (NYSE:HUM) by 6.7% in the third quarter, HoldingsChannel reports. The firm owned 736 shares of the insurance provider’s stock after buying an additional 46 shares during the period. Brooklyn Investment Group’s holdings in Humana were worth $233,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Mendota Financial Group LLC raised its stake in shares of Humana by 9.2% during the 2nd quarter. Mendota Financial Group LLC now owns 319 shares of the insurance provider’s stock valued at $119,000 after buying an additional 27 shares during the last quarter. Capital Advisors Ltd. LLC raised its position in Humana by 17.0% during the second quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock valued at $80,000 after acquiring an additional 31 shares in the last quarter. CarsonAllaria Wealth Management Ltd. boosted its position in Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after purchasing an additional 39 shares in the last quarter. Moors & Cabot Inc. lifted its stake in shares of Humana by 2.5% in the 3rd quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock valued at $519,000 after purchasing an additional 40 shares during the period. Finally, Harbour Investments Inc. raised its position in shares of Humana by 10.5% in the second quarter. Harbour Investments Inc. now owns 432 shares of the insurance provider’s stock worth $161,000 after acquiring an additional 41 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently issued reports on HUM shares. Piper Sandler cut Humana from an “overweight” rating to a “neutral” rating and lowered their price objective for the stock from $392.00 to $274.00 in a report on Thursday, October 3rd. Stephens reaffirmed an “equal weight” rating and issued a $250.00 price objective on shares of Humana in a research note on Wednesday, October 9th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $395.00 price objective on shares of Humana in a research report on Tuesday, October 1st. Leerink Partnrs downgraded Humana from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Finally, Bank of America upgraded Humana from an “underperform” rating to a “neutral” rating and lifted their price objective for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. Twenty equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, Humana has an average rating of “Hold” and an average price target of $315.86.

Humana Stock Performance

Shares of HUM opened at $295.49 on Wednesday. The firm has a market cap of $35.58 billion, a PE ratio of 26.17, a price-to-earnings-growth ratio of 2.40 and a beta of 0.52. The company’s 50 day simple moving average is $276.28 and its 200-day simple moving average is $330.23. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $527.18.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping the consensus estimate of $3.48 by $0.68. The business had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. As a group, equities analysts predict that Humana Inc. will post 15.86 EPS for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a yield of 1.20%. Humana’s dividend payout ratio (DPR) is 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.